Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-25-000800
Filing Date
2025-05-13
Accepted
2025-05-13 21:06:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 13625
  Complete submission text file 0001753926-25-000800.txt   15621
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Subject) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-83146 | Film No.: 25942288
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 140 BROADWAY 38TH FLOOR NEW YORK NY 10005
Business Address 874 WALKER ROAD SUITE C DOVER DE 19904 (646) 845-0040
3i, LP (Filed by) CIK: 0001841619 (see all company filings)

EIN.: 843800874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A